カテゴリー： Market Monitor Global, 世界, 医療/バイオ

腫瘍治療薬の世界市場見通し2023年-2029年

◆英語タイトル：Oncology Therapeutic Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5829）

◆商品コード：MMG23JU5829
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：120
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Oncology Therapeutic Drug Market 調査レポートは次の情報を含め、グローバルにおけるの腫瘍治療薬市場規模と予測を収録しています。・世界の腫瘍治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の腫瘍治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の腫瘍治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「化学療法」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

腫瘍治療薬のグローバル主要企業は、AbbVie、 Amgen、 Astellas Pharma、 AstraZeneca、 Bayer、 Biogen、 Bristol Myers Squibb、 Celgene、 Eisai、 Eli Lilly and Company、 Gilead Sciences、 Ipsen、 Johnson and Johnson、 Merck、 Novartis、 Otsuka Pharmaceutical、 Pfizer、 F. Hoffmann-La Roche、 Sanofi、 Takeda Pharmaceutical、 Teva Pharmaceutical Industriesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、腫瘍治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の腫瘍治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の腫瘍治療薬市場：タイプ別市場シェア、2022年
・化学療法、標的療法、免疫療法、ホルモン療法、その他

世界の腫瘍治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の腫瘍治療薬市場：用途別市場シェア、2022年
・乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他

世界の腫瘍治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の腫瘍治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における腫瘍治療薬のグローバル売上、2018年-2023年
・主要企業における腫瘍治療薬のグローバル売上シェア、2022年
・主要企業における腫瘍治療薬のグローバル販売量、2018年-2023年
・主要企業における腫瘍治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
AbbVie、 Amgen、 Astellas Pharma、 AstraZeneca、 Bayer、 Biogen、 Bristol Myers Squibb、 Celgene、 Eisai、 Eli Lilly and Company、 Gilead Sciences、 Ipsen、 Johnson and Johnson、 Merck、 Novartis、 Otsuka Pharmaceutical、 Pfizer、 F. Hoffmann-La Roche、 Sanofi、 Takeda Pharmaceutical、 Teva Pharmaceutical Industries

*************************************************************

・調査・分析レポートの概要
腫瘍治療薬市場の定義
市場セグメント
世界の腫瘍治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の腫瘍治療薬市場規模
世界の腫瘍治療薬市場規模：2022年 VS 2029年
世界の腫瘍治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの腫瘍治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の腫瘍治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：化学療法、標的療法、免疫療法、ホルモン療法、その他
腫瘍治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：乳がん、消化器がん、前立腺がん、呼吸器・肺がん、その他
腫瘍治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別腫瘍治療薬市場規模 2022年と2029年
地域別腫瘍治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
AbbVie、 Amgen、 Astellas Pharma、 AstraZeneca、 Bayer、 Biogen、 Bristol Myers Squibb、 Celgene、 Eisai、 Eli Lilly and Company、 Gilead Sciences、 Ipsen、 Johnson and Johnson、 Merck、 Novartis、 Otsuka Pharmaceutical、 Pfizer、 F. Hoffmann-La Roche、 Sanofi、 Takeda Pharmaceutical、 Teva Pharmaceutical Industries
...

Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.

When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.

Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.

Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
This report aims to provide a comprehensive presentation of the global market for Oncology Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oncology Therapeutic Drug. This report contains market size and forecasts of Oncology Therapeutic Drug in global, including the following market information:
Global Oncology Therapeutic Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oncology Therapeutic Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oncology Therapeutic Drug companies in 2022 (%)
The global Oncology Therapeutic Drug market was valued at US$ 203160 million in 2022 and is projected to reach US$ 340480 million by 2029, at a CAGR of 7.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The industry’s leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oncology Therapeutic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oncology Therapeutic Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Therapeutic Drug Market Segment Percentages, by Type, 2022 (%)
Chemotherapy
Targeted Therapy
Immunotherapy
Hormonal Therapy
Others
Global Oncology Therapeutic Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Therapeutic Drug Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory and Lung Cancer
Others
Global Oncology Therapeutic Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oncology Therapeutic Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oncology Therapeutic Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oncology Therapeutic Drug revenues share in global market, 2022 (%)
Key companies Oncology Therapeutic Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oncology Therapeutic Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Astellas Pharma
AstraZeneca
Bayer
Biogen
Bristol Myers Squibb
Celgene
Eisai
Eli Lilly and Company
Gilead Sciences
Ipsen
Johnson and Johnson
Merck
Novartis
Otsuka Pharmaceutical
Pfizer
F. Hoffmann-La Roche
Sanofi
Takeda Pharmaceutical
Teva Pharmaceutical Industries
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oncology Therapeutic Drug, market overview.
Chapter 2: Global Oncology Therapeutic Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Oncology Therapeutic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oncology Therapeutic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oncology Therapeutic Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Oncology Therapeutic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oncology Therapeutic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oncology Therapeutic Drug Overall Market Size
2.1 Global Oncology Therapeutic Drug Market Size: 2022 VS 2029
2.2 Global Oncology Therapeutic Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oncology Therapeutic Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Oncology Therapeutic Drug Players in Global Market
3.2 Top Global Oncology Therapeutic Drug Companies Ranked by Revenue
3.3 Global Oncology Therapeutic Drug Revenue by Companies
3.4 Global Oncology Therapeutic Drug Sales by Companies
3.5 Global Oncology Therapeutic Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oncology Therapeutic Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oncology Therapeutic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oncology Therapeutic Drug Players in Global Market
3.8.1 List of Global Tier 1 Oncology Therapeutic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Oncology Therapeutic Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oncology Therapeutic Drug Market Size Markets, 2022 & 2029
4.1.2 Chemotherapy
4.1.3 Targeted Therapy
4.1.4 Immunotherapy
4.1.5 Hormonal Therapy
4.1.6 Others
4.2 By Type – Global Oncology Therapeutic Drug Revenue & Forecasts
4.2.1 By Type – Global Oncology Therapeutic Drug Revenue, 2018-2023
4.2.2 By Type – Global Oncology Therapeutic Drug Revenue, 2024-2029
4.2.3 By Type – Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Oncology Therapeutic Drug Sales & Forecasts
4.3.1 By Type – Global Oncology Therapeutic Drug Sales, 2018-2023
4.3.2 By Type – Global Oncology Therapeutic Drug Sales, 2024-2029
4.3.3 By Type – Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
4.4 By Type – Global Oncology Therapeutic Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oncology Therapeutic Drug Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Gastrointestinal Cancer
5.1.4 Prostate Cancer
5.1.5 Respiratory and Lung Cancer
5.1.6 Others
5.2 By Application – Global Oncology Therapeutic Drug Revenue & Forecasts
5.2.1 By Application – Global Oncology Therapeutic Drug Revenue, 2018-2023
5.2.2 By Application – Global Oncology Therapeutic Drug Revenue, 2024-2029
5.2.3 By Application – Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Oncology Therapeutic Drug Sales & Forecasts
5.3.1 By Application – Global Oncology Therapeutic Drug Sales, 2018-2023
5.3.2 By Application – Global Oncology Therapeutic Drug Sales, 2024-2029
5.3.3 By Application – Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
5.4 By Application – Global Oncology Therapeutic Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oncology Therapeutic Drug Market Size, 2022 & 2029
6.2 By Region – Global Oncology Therapeutic Drug Revenue & Forecasts
6.2.1 By Region – Global Oncology Therapeutic Drug Revenue, 2018-2023
6.2.2 By Region – Global Oncology Therapeutic Drug Revenue, 2024-2029
6.2.3 By Region – Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Oncology Therapeutic Drug Sales & Forecasts
6.3.1 By Region – Global Oncology Therapeutic Drug Sales, 2018-2023
6.3.2 By Region – Global Oncology Therapeutic Drug Sales, 2024-2029
6.3.3 By Region – Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oncology Therapeutic Drug Revenue, 2018-2029
6.4.2 By Country – North America Oncology Therapeutic Drug Sales, 2018-2029
6.4.3 US Oncology Therapeutic Drug Market Size, 2018-2029
6.4.4 Canada Oncology Therapeutic Drug Market Size, 2018-2029
6.4.5 Mexico Oncology Therapeutic Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oncology Therapeutic Drug Revenue, 2018-2029
6.5.2 By Country – Europe Oncology Therapeutic Drug Sales, 2018-2029
6.5.3 Germany Oncology Therapeutic Drug Market Size, 2018-2029
6.5.4 France Oncology Therapeutic Drug Market Size, 2018-2029
6.5.5 U.K. Oncology Therapeutic Drug Market Size, 2018-2029
6.5.6 Italy Oncology Therapeutic Drug Market Size, 2018-2029
6.5.7 Russia Oncology Therapeutic Drug Market Size, 2018-2029
6.5.8 Nordic Countries Oncology Therapeutic Drug Market Size, 2018-2029
6.5.9 Benelux Oncology Therapeutic Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oncology Therapeutic Drug Revenue, 2018-2029
6.6.2 By Region – Asia Oncology Therapeutic Drug Sales, 2018-2029
6.6.3 China Oncology Therapeutic Drug Market Size, 2018-2029
6.6.4 Japan Oncology Therapeutic Drug Market Size, 2018-2029
6.6.5 South Korea Oncology Therapeutic Drug Market Size, 2018-2029
6.6.6 Southeast Asia Oncology Therapeutic Drug Market Size, 2018-2029
6.6.7 India Oncology Therapeutic Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oncology Therapeutic Drug Revenue, 2018-2029
6.7.2 By Country – South America Oncology Therapeutic Drug Sales, 2018-2029
6.7.3 Brazil Oncology Therapeutic Drug Market Size, 2018-2029
6.7.4 Argentina Oncology Therapeutic Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oncology Therapeutic Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oncology Therapeutic Drug Sales, 2018-2029
6.8.3 Turkey Oncology Therapeutic Drug Market Size, 2018-2029
6.8.4 Israel Oncology Therapeutic Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Oncology Therapeutic Drug Market Size, 2018-2029
6.8.6 UAE Oncology Therapeutic Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Oncology Therapeutic Drug Major Product Offerings
7.1.4 AbbVie Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.1.5 AbbVie Key News & Latest Developments
7.2 Amgen
7.2.1 Amgen Company Summary
7.2.2 Amgen Business Overview
7.2.3 Amgen Oncology Therapeutic Drug Major Product Offerings
7.2.4 Amgen Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.2.5 Amgen Key News & Latest Developments
7.3 Astellas Pharma
7.3.1 Astellas Pharma Company Summary
7.3.2 Astellas Pharma Business Overview
7.3.3 Astellas Pharma Oncology Therapeutic Drug Major Product Offerings
7.3.4 Astellas Pharma Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.3.5 Astellas Pharma Key News & Latest Developments
7.4 AstraZeneca
7.4.1 AstraZeneca Company Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca Oncology Therapeutic Drug Major Product Offerings
7.4.4 AstraZeneca Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.4.5 AstraZeneca Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Oncology Therapeutic Drug Major Product Offerings
7.5.4 Bayer Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 Biogen
7.6.1 Biogen Company Summary
7.6.2 Biogen Business Overview
7.6.3 Biogen Oncology Therapeutic Drug Major Product Offerings
7.6.4 Biogen Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.6.5 Biogen Key News & Latest Developments
7.7 Bristol Myers Squibb
7.7.1 Bristol Myers Squibb Company Summary
7.7.2 Bristol Myers Squibb Business Overview
7.7.3 Bristol Myers Squibb Oncology Therapeutic Drug Major Product Offerings
7.7.4 Bristol Myers Squibb Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.7.5 Bristol Myers Squibb Key News & Latest Developments
7.8 Celgene
7.8.1 Celgene Company Summary
7.8.2 Celgene Business Overview
7.8.3 Celgene Oncology Therapeutic Drug Major Product Offerings
7.8.4 Celgene Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.8.5 Celgene Key News & Latest Developments
7.9 Eisai
7.9.1 Eisai Company Summary
7.9.2 Eisai Business Overview
7.9.3 Eisai Oncology Therapeutic Drug Major Product Offerings
7.9.4 Eisai Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.9.5 Eisai Key News & Latest Developments
7.10 Eli Lilly and Company
7.10.1 Eli Lilly and Company Company Summary
7.10.2 Eli Lilly and Company Business Overview
7.10.3 Eli Lilly and Company Oncology Therapeutic Drug Major Product Offerings
7.10.4 Eli Lilly and Company Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.10.5 Eli Lilly and Company Key News & Latest Developments
7.11 Gilead Sciences
7.11.1 Gilead Sciences Company Summary
7.11.2 Gilead Sciences Oncology Therapeutic Drug Business Overview
7.11.3 Gilead Sciences Oncology Therapeutic Drug Major Product Offerings
7.11.4 Gilead Sciences Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.11.5 Gilead Sciences Key News & Latest Developments
7.12 Ipsen
7.12.1 Ipsen Company Summary
7.12.2 Ipsen Oncology Therapeutic Drug Business Overview
7.12.3 Ipsen Oncology Therapeutic Drug Major Product Offerings
7.12.4 Ipsen Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.12.5 Ipsen Key News & Latest Developments
7.13 Johnson and Johnson
7.13.1 Johnson and Johnson Company Summary
7.13.2 Johnson and Johnson Oncology Therapeutic Drug Business Overview
7.13.3 Johnson and Johnson Oncology Therapeutic Drug Major Product Offerings
7.13.4 Johnson and Johnson Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.13.5 Johnson and Johnson Key News & Latest Developments
7.14 Merck
7.14.1 Merck Company Summary
7.14.2 Merck Business Overview
7.14.3 Merck Oncology Therapeutic Drug Major Product Offerings
7.14.4 Merck Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.14.5 Merck Key News & Latest Developments
7.15 Novartis
7.15.1 Novartis Company Summary
7.15.2 Novartis Business Overview
7.15.3 Novartis Oncology Therapeutic Drug Major Product Offerings
7.15.4 Novartis Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.15.5 Novartis Key News & Latest Developments
7.16 Otsuka Pharmaceutical
7.16.1 Otsuka Pharmaceutical Company Summary
7.16.2 Otsuka Pharmaceutical Business Overview
7.16.3 Otsuka Pharmaceutical Oncology Therapeutic Drug Major Product Offerings
7.16.4 Otsuka Pharmaceutical Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.16.5 Otsuka Pharmaceutical Key News & Latest Developments
7.17 Pfizer
7.17.1 Pfizer Company Summary
7.17.2 Pfizer Business Overview
7.17.3 Pfizer Oncology Therapeutic Drug Major Product Offerings
7.17.4 Pfizer Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.17.5 Pfizer Key News & Latest Developments
7.18 F. Hoffmann-La Roche
7.18.1 F. Hoffmann-La Roche Company Summary
7.18.2 F. Hoffmann-La Roche Business Overview
7.18.3 F. Hoffmann-La Roche Oncology Therapeutic Drug Major Product Offerings
7.18.4 F. Hoffmann-La Roche Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.18.5 F. Hoffmann-La Roche Key News & Latest Developments
7.19 Sanofi
7.19.1 Sanofi Company Summary
7.19.2 Sanofi Business Overview
7.19.3 Sanofi Oncology Therapeutic Drug Major Product Offerings
7.19.4 Sanofi Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.19.5 Sanofi Key News & Latest Developments
7.20 Takeda Pharmaceutical
7.20.1 Takeda Pharmaceutical Company Summary
7.20.2 Takeda Pharmaceutical Business Overview
7.20.3 Takeda Pharmaceutical Oncology Therapeutic Drug Major Product Offerings
7.20.4 Takeda Pharmaceutical Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.20.5 Takeda Pharmaceutical Key News & Latest Developments
7.21 Teva Pharmaceutical Industries
7.21.1 Teva Pharmaceutical Industries Company Summary
7.21.2 Teva Pharmaceutical Industries Business Overview
7.21.3 Teva Pharmaceutical Industries Oncology Therapeutic Drug Major Product Offerings
7.21.4 Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales and Revenue in Global (2018-2023)
7.21.5 Teva Pharmaceutical Industries Key News & Latest Developments
8 Global Oncology Therapeutic Drug Production Capacity, Analysis
8.1 Global Oncology Therapeutic Drug Production Capacity, 2018-2029
8.2 Oncology Therapeutic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oncology Therapeutic Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oncology Therapeutic Drug Supply Chain Analysis
10.1 Oncology Therapeutic Drug Industry Value Chain
10.2 Oncology Therapeutic Drug Upstream Market
10.3 Oncology Therapeutic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oncology Therapeutic Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Oncology Therapeutic Drug in Global Market
Table 2. Top Oncology Therapeutic Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Oncology Therapeutic Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Oncology Therapeutic Drug Revenue Share by Companies, 2018-2023
Table 5. Global Oncology Therapeutic Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Oncology Therapeutic Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Oncology Therapeutic Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Oncology Therapeutic Drug Product Type
Table 9. List of Global Tier 1 Oncology Therapeutic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Oncology Therapeutic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Oncology Therapeutic Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Oncology Therapeutic Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Oncology Therapeutic Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Oncology Therapeutic Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Oncology Therapeutic Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Oncology Therapeutic Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Oncology Therapeutic Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Oncology Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Oncology Therapeutic Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Oncology Therapeutic Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Oncology Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Oncology Therapeutic Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Oncology Therapeutic Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Oncology Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Oncology Therapeutic Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Oncology Therapeutic Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Oncology Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Oncology Therapeutic Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Oncology Therapeutic Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Oncology Therapeutic Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Oncology Therapeutic Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Oncology Therapeutic Drug Sales, (K Units), 2024-2029
Table 46. AbbVie Company Summary
Table 47. AbbVie Oncology Therapeutic Drug Product Offerings
Table 48. AbbVie Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. AbbVie Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Oncology Therapeutic Drug Product Offerings
Table 52. Amgen Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Astellas Pharma Company Summary
Table 55. Astellas Pharma Oncology Therapeutic Drug Product Offerings
Table 56. Astellas Pharma Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Astellas Pharma Key News & Latest Developments
Table 58. AstraZeneca Company Summary
Table 59. AstraZeneca Oncology Therapeutic Drug Product Offerings
Table 60. AstraZeneca Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. AstraZeneca Key News & Latest Developments
Table 62. Bayer Company Summary
Table 63. Bayer Oncology Therapeutic Drug Product Offerings
Table 64. Bayer Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Bayer Key News & Latest Developments
Table 66. Biogen Company Summary
Table 67. Biogen Oncology Therapeutic Drug Product Offerings
Table 68. Biogen Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Biogen Key News & Latest Developments
Table 70. Bristol Myers Squibb Company Summary
Table 71. Bristol Myers Squibb Oncology Therapeutic Drug Product Offerings
Table 72. Bristol Myers Squibb Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Bristol Myers Squibb Key News & Latest Developments
Table 74. Celgene Company Summary
Table 75. Celgene Oncology Therapeutic Drug Product Offerings
Table 76. Celgene Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Celgene Key News & Latest Developments
Table 78. Eisai Company Summary
Table 79. Eisai Oncology Therapeutic Drug Product Offerings
Table 80. Eisai Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Eisai Key News & Latest Developments
Table 82. Eli Lilly and Company Company Summary
Table 83. Eli Lilly and Company Oncology Therapeutic Drug Product Offerings
Table 84. Eli Lilly and Company Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Eli Lilly and Company Key News & Latest Developments
Table 86. Gilead Sciences Company Summary
Table 87. Gilead Sciences Oncology Therapeutic Drug Product Offerings
Table 88. Gilead Sciences Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Gilead Sciences Key News & Latest Developments
Table 90. Ipsen Company Summary
Table 91. Ipsen Oncology Therapeutic Drug Product Offerings
Table 92. Ipsen Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Ipsen Key News & Latest Developments
Table 94. Johnson and Johnson Company Summary
Table 95. Johnson and Johnson Oncology Therapeutic Drug Product Offerings
Table 96. Johnson and Johnson Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Johnson and Johnson Key News & Latest Developments
Table 98. Merck Company Summary
Table 99. Merck Oncology Therapeutic Drug Product Offerings
Table 100. Merck Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Merck Key News & Latest Developments
Table 102. Novartis Company Summary
Table 103. Novartis Oncology Therapeutic Drug Product Offerings
Table 104. Novartis Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Novartis Key News & Latest Developments
Table 106. Otsuka Pharmaceutical Company Summary
Table 107. Otsuka Pharmaceutical Oncology Therapeutic Drug Product Offerings
Table 108. Otsuka Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Otsuka Pharmaceutical Key News & Latest Developments
Table 110. Pfizer Company Summary
Table 111. Pfizer Oncology Therapeutic Drug Product Offerings
Table 112. Pfizer Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Pfizer Key News & Latest Developments
Table 114. F. Hoffmann-La Roche Company Summary
Table 115. F. Hoffmann-La Roche Oncology Therapeutic Drug Product Offerings
Table 116. F. Hoffmann-La Roche Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. F. Hoffmann-La Roche Key News & Latest Developments
Table 118. Sanofi Company Summary
Table 119. Sanofi Oncology Therapeutic Drug Product Offerings
Table 120. Sanofi Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. Sanofi Key News & Latest Developments
Table 122. Takeda Pharmaceutical Company Summary
Table 123. Takeda Pharmaceutical Oncology Therapeutic Drug Product Offerings
Table 124. Takeda Pharmaceutical Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. Takeda Pharmaceutical Key News & Latest Developments
Table 126. Teva Pharmaceutical Industries Company Summary
Table 127. Teva Pharmaceutical Industries Oncology Therapeutic Drug Product Offerings
Table 128. Teva Pharmaceutical Industries Oncology Therapeutic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 129. Teva Pharmaceutical Industries Key News & Latest Developments
Table 130. Oncology Therapeutic Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 131. Global Oncology Therapeutic Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 132. Global Oncology Therapeutic Drug Production by Region, 2018-2023 (K Units)
Table 133. Global Oncology Therapeutic Drug Production by Region, 2024-2029 (K Units)
Table 134. Oncology Therapeutic Drug Market Opportunities & Trends in Global Market
Table 135. Oncology Therapeutic Drug Market Drivers in Global Market
Table 136. Oncology Therapeutic Drug Market Restraints in Global Market
Table 137. Oncology Therapeutic Drug Raw Materials
Table 138. Oncology Therapeutic Drug Raw Materials Suppliers in Global Market
Table 139. Typical Oncology Therapeutic Drug Downstream
Table 140. Oncology Therapeutic Drug Downstream Clients in Global Market
Table 141. Oncology Therapeutic Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Oncology Therapeutic Drug Segment by Type in 2022
Figure 2. Oncology Therapeutic Drug Segment by Application in 2022
Figure 3. Global Oncology Therapeutic Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Oncology Therapeutic Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Oncology Therapeutic Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Oncology Therapeutic Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Oncology Therapeutic Drug Revenue in 2022
Figure 9. By Type - Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Oncology Therapeutic Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Oncology Therapeutic Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Oncology Therapeutic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Oncology Therapeutic Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 23. US Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 28. Germany Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 37. China Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 44. Brazil Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Oncology Therapeutic Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Oncology Therapeutic Drug Sales Market Share, 2018-2029
Figure 48. Turkey Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Oncology Therapeutic Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Oncology Therapeutic Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Oncology Therapeutic Drug by Region, 2022 VS 2029
Figure 54. Oncology Therapeutic Drug Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 腫瘍治療薬の世界市場見通し2023年-2029年(Oncology Therapeutic Drug Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

腫瘍治療薬の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp